Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autoimmune/inflammatory syndrome induced by mineral oil: a health problem.
Vera-Lastra O, Medina G, Cruz-Domínguez MP, Ramírez GM, Blancas RBP, Amaro ALP, Martínez AV, Delgado JS, Jara LJ. Vera-Lastra O, et al. Among authors: ramirez gm. Clin Rheumatol. 2018 Jun;37(6):1441-1448. doi: 10.1007/s10067-018-4078-2. Epub 2018 Apr 4. Clin Rheumatol. 2018. PMID: 29619588 Review.
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.
Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro Benallal D, Benítez Roldán A, Merino V, Ramirez G, Calleja-Hernández MA, Caunedo Álvarez A, Romero Gómez M. Argüelles-Arias F, et al. Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1290-1295. doi: 10.1097/MEG.0000000000000953. Eur J Gastroenterol Hepatol. 2017. PMID: 28902041 Free PMC article.
Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro D, Benítez Roldán A, Merino V, Ramírez G, Caunedo Álvarez A, Romero Gómez M. Argüelles-Arias F, et al. Dig Dis Sci. 2017 Aug;62(8):2203. doi: 10.1007/s10620-017-4657-0. Dig Dis Sci. 2017. PMID: 28660487 Free PMC article. No abstract available.
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro D, Benítez Roldán A, Merino V, Ramírez G, Caunedo Álvarez A, Romero Gómez M. Argüelles-Arias F, et al. Dig Dis Sci. 2017 May;62(5):1305-1312. doi: 10.1007/s10620-017-4511-4. Epub 2017 Mar 9. Dig Dis Sci. 2017. PMID: 28281165 Free PMC article.
The economic burden of systemic lupus erythematosus in Mexico.
Elsisi GH, Andrade-Ortega L, Portela M, Ramírez GM. Elsisi GH, et al. Among authors: ramirez gm. J Med Econ. 2024;27(sup1):12-22. doi: 10.1080/13696998.2024.2322263. Epub 2024 Mar 11. J Med Econ. 2024. PMID: 38468477 Free article.
Interpregnancy interval and prevalence of selected birth defects: A multistate study.
Liberman RF, Heinke D, Petersen JM, Parker SE, Nestoridi E, Van Zutphen AR, Nembhard WN, Ramirez GM, Ethen MK, Tran T, Kirby RS, Getz KD, Nance AE, Yazdy MM; National Birth Defects Prevention Network. Liberman RF, et al. Among authors: ramirez gm. Birth Defects Res. 2022 Jan 15;114(2):69-79. doi: 10.1002/bdr2.1960. Epub 2021 Oct 21. Birth Defects Res. 2022. PMID: 34676681
23 results